Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Dabigatran-etexilate

Traumatic acute subdural haematoma: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Avila RI, et al. Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: A case report of first use in Latin America. European Heart Journal - Case Reports 3: no pagination, No. 2, Jun 2019. Available from: URL: http://doi.org/10.1093/ehjcr/ytz098 - Mexico Avila RI, et al. Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: A case report of first use in Latin America. European Heart Journal - Case Reports 3: no pagination, No. 2, Jun 2019. Available from: URL: http://​doi.​org/​10.​1093/​ehjcr/​ytz098 - Mexico
Metadaten
Titel
Dabigatran-etexilate
Traumatic acute subdural haematoma: case report
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-68881-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Erlotinib

Case report

Pembrolizumab

Case report

Multiple drugs

Case report

Acitretin